Standard medical management is named as a drug or biological intervention in 4 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Beijing Tiantan Hospital (1), First Hospital of China Medical University (1) and The First Affiliated Hospital of University of Science and Technology of China (1). Registered phases: Phase 3 and Not applicable. Conditions studied include Ischemic Stroke; Medium Vessel Occlusion; Tenecteplase.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07357987 | Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke (ClinicalTrials.gov ↗) Ischemic Stroke, Medium Vessel Occlusion, Tenecteplase |
Phase 3 | Recruiting |
| NCT07094763 | Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset (ClinicalTrials.gov ↗) Acute Ischemic Stroke |
Not applicable | Recruiting |
| NCT07476898 | Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window (ClinicalTrials.gov ↗) Stroke |
Phase 3 | Not yet open |
| NCT07386262 | A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke (ClinicalTrials.gov ↗) Cerebral Edema, Ischemic Stroke, Acute, Malignant Cerebral Edema |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Ischemic Stroke | 1 |
| Medium Vessel Occlusion | 1 |
| Tenecteplase | 1 |
| Endovascular Treatment | 1 |
| Stroke | 1 |
| Acute Ischemic Stroke | 1 |
| Cerebral Edema | 1 |
| Ischemic Stroke, Acute | 1 |
| Malignant Cerebral Edema | 1 |
| Anterior Circulation Brain Infarction | 1 |
| Lead sponsor | Trials |
|---|---|
| Beijing Tiantan Hospital | 1 |
| First Hospital of China Medical University | 1 |
| The First Affiliated Hospital of University of Science and Technology of China | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Register | Standard medical management trials |
|---|---|
| Clinical trials in China | 4 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Standard medical management works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Standard medical management (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.